Harding Loevner’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261M | Buy |
|
|||||
|
2025
Q1 | $247M | Sell |
|
|||||
|
2024
Q4 | $255M | Sell |
|
|||||
|
2024
Q3 | $291M | Buy |
|
|||||
|
2024
Q2 | $221M | Sell |
|
|||||
|
2024
Q1 | $250M | Sell |
|
|||||
|
2023
Q4 | $264M | Sell |
|
|||||
|
2023
Q3 | $256M | Sell |
|
|||||
|
2023
Q2 | $270M | Sell |
|
|||||
|
2023
Q1 | $322M | Buy |
|
|||||
|
2022
Q4 | $177M | Buy |
|
|||||
|
2022
Q3 | $167M | Sell |
|
|||||
|
2022
Q2 | $205M | Sell |
|
|||||
|
2022
Q1 | $266M | Sell |
|
|||||
|
2021
Q4 | $326M | Sell |
|
|||||
|
2021
Q3 | $281M | Sell |
|
|||||
|
2021
Q2 | $327M | Sell |
|
|||||
|
2021
Q1 | $515M | Buy |
|
|||||
|
2020
Q4 | $321M | Buy |
|
|||||
|
2020
Q3 | $265M | Buy |
|